Latest Prodrugs Stories
-- Studies focused on patients where there is a high unmet need today or anticipated in the near future -- BOSTON, Nov.
PRINCETON, N.J., Nov. 5, 2014 /PRNewswire/ -- Ranbaxy Laboratories Limited (RLL) announced today that the Company has received approval from the U.S.
REHOVOT, Israel, October 29, 2014 /PRNewswire/ -- Company also reports encouraging partial results from Phase IIa study of continuous, subcutaneously delivered high-dose
BUFFALO, N.Y., Oct.
Sales of a Novel Antipsychotic and an Improved Rescue Therapy Will Contribute Approximately $1 Billion to the PD Market in 2023, According to Findings from Decision Resources Group BURLINGTON,
- Pertaining to the surface or end opposite to the mouth in a radiate animal.